Why Assuring the Quality of Antimicrobials Is a Global Imperative

Area of Science:

• Pharmaceutical Sciences
• Global Health Security
• Medicinal Chemistry

Background:

• Substandard and falsified antimicrobial medicines are a significant global threat.
• Poor-quality drugs compromise treatment efficacy and patient safety.
• Low- and middle-income countries disproportionately affected by counterfeit medicines.

Purpose of the Study:

• To discuss the multifaceted risks associated with poor-quality antimicrobial medicines.
• To highlight the link between substandard antimicrobials and antimicrobial resistance.
• To recommend policy and regulatory interventions for supply chain improvement.

Main Methods:

• Literature review of antimicrobial drug quality issues.
• Analysis of supply chain vulnerabilities.
• Synthesis of regulatory and policy recommendations.

Main Results:

• Poor-quality antimicrobials contribute to treatment failures and adverse events.
• Substandard medicines exacerbate the crisis of antimicrobial resistance.
• Existing supply chains lack robust mechanisms for quality assurance.

Conclusions:

• Strengthening regulatory oversight is crucial for ensuring antimicrobial quality.
• Policy reforms are needed to build resilient pharmaceutical supply chains.
• International collaboration is essential to combat the proliferation of poor-quality medicines.